Clinical Research News
-
Ascentage Pharma presents new clinical data of apoptosis targeted drug candidates
Clinical Research | News | 0 Comment | 07 Jun, 2019
Ascentage Pharma, a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies for can...Read more
-
CStone to initiate clinical development of CS1001 and BLU-554 in combination therapy for HCC
Clinical Research | News | 0 Comment | 06 Jun, 2019
CStone Pharmaceuticals has announced that it has received approval to initiate clinical development in C...Read more
-
Genentech announces meeting of primary endpoint of Ph III study
Clinical Research | News | 0 Comment | 04 Jun, 2019
Genentech, a member of the Roche Group has announced that the Phase III BLOCKSTONE study, conducted by Shionogi &am...Read more
-
Saluda Medical announces clinical study results of the chronic pain treatment
Clinical Research | News | 0 Comment | 03 Jun, 2019
Saluda Medical Pty Limited ("Saluda Medical") has announced data from two clinical studies evaluating the performance of...Read more
-
Innovent announces preliminary results of Sintilimab at ASCO
Clinical Research | News | 0 Comment | 31 May, 2019
Innovent Biologics, a world-class biopharmaceutical company that develops and commercializes high quality medicines...Read more
-
Pi Therapeutics announces $19.7 M Series B Financing
Clinical Research | News | 0 Comment | 30 May, 2019
Pi Therapeutics, a company dedicated to the development of novel modulators of protein degradation for cancer has announ...Read more
-
Up to six new HBV drugs set to launch by 2027, with China driving market growth, says GlobalData
Clinical Research | News | 0 Comment | 29 May, 2019
Within the next ten years, up to six new drugs are projected to be approved for the treatment of chronic hepatitis B vir...Read more
-
Agios's Phase 3 ClarlDHy trial of TIBSOVO meet its primary endpoint
Clinical Research | News | 0 Comment | 28 May, 2019
The partner of CStone Pharmaceuticals, Agios Pharmaceuticals has announced that the global Phase 3 ClarIDHy trial o...Read more
-
Takeda announces results of Phase 3b VARSITY studies
Clinical Research | News | 0 Comment | 20 May, 2019
Takeda Pharmaceutical Company Limited has announced further results from the Phase 3b head-to-head VARSITY study, w...Read more
-
Study demonstrates Clinical Utility of Liquid Biopsy for Cancer Monitoring
Clinical Research | News | 0 Comment | 17 May, 2019
Growing scientific evidence supports liquid biopsy as a valuable tool for monitoring treatment response in patients with...Read more
-
Clinical Research | News | 0 Comment | 15 May, 2019
Ping An Insurance Company of China has announced that its technology arm, Ping An Technology, has c...Read more
-
Promethera Biosciences makes progress in HepaStem development programme
Clinical Research | News | 0 Comment | 09 May, 2019
Promethera Biosciences SA, a global innovator in cell-based medicines and liver diseases, has announced the dosing of a ...Read more
-
WISE enrolls first patient in pivotal clinical study of novel neuro-electrodes for brain monitoring
Clinical Research | News | 0 Comment | 08 May, 2019
WISE Srl, a medical device company developing next-generation implantable leads for neuromonitoring and neuromodulation,...Read more
-
AstraZeneca’s Calquence phase III ASCEND trial meets positive result
Clinical Research | News | 0 Comment | 08 May, 2019
AstraZeneca announced positive results from the phase III ASCEND trial of Calquence (acalabrutinib) in previously-treate...Read more
-
Daiichi Sankyo- AstraZeneca’s breast cancer drug reveals positive response
Clinical Research | News | 0 Comment | 08 May, 2019
Daiichi Sankyo Company, Limited (Daiichi Sankyo) and AstraZeneca have announced positive topline results for the pivotal...Read more
-
Innovent Biologics, Eli Lilly has announced that IBI301 has met pre-defined primary endpoints
Clinical Research | News | 0 Comment | 08 May, 2019
Innovent Biologics and Eli Lilly and Company has jointly announced that IBI301, a recombinant human-mouse...Read more
-
VolitionRx initiates clinical trial programme in lung cancer
Clinical Research | News | 0 Comment | 08 May, 2019
US based VolitionRx Limited has announced that it has added to its extensive clinical trial programme with the execution...Read more
-
Clinical research is becoming more disintegrated with the influx of data from different sources
Clinical Research | Opinion | 0 Comment | 07 May, 2019
Asia Pacific is expected to become the destination of choice for clinical trials due to its fast-growing pharmaceutical ...Read more
